Literature DB >> 25704182

Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer.

Etmar Bulk1, Anne-Sophie Ay2, Mehdi Hammadi2,3, Halima Ouadid-Ahidouch2, Sonja Schelhaas4, Antje Hascher5, Christian Rohde5,6, Nils H Thoennissen5,7, Rainer Wiewrodt5, Eva Schmidt5, Alessandro Marra8, Ludger Hillejan8, Andreas H Jacobs4,9, Hans-Ulrich Klein10, Martin Dugas10, Wolfgang E Berdel5, Carsten Müller-Tidow5,6, Albrecht Schwab1.   

Abstract

Epigenomic changes are an important feature of malignant tumors. How tumor aggressiveness is affected by DNA methylation of specific loci is largely unexplored. In genome-wide DNA methylation analyses, we identified the KCa 3.1 channel gene (KCNN4) promoter to be hypomethylated in an aggressive non-small-cell lung carcinoma (NSCLC) cell line and in patient samples. Accordingly, KCa 3.1 expression was increased in more aggressive NSCLC cells. Both findings were strong predictors for poor prognosis in lung adenocarcinoma. Increased KCa 3.1 expression was associated with aggressive features of NSCLC cells. Proliferation and migration of pro-metastatic NSCLC cells depended on KCa 3.1 activity. Mechanistically, elevated KCa 3.1 expression hyperpolarized the membrane potential, thereby augmenting the driving force for Ca(2+) influx. KCa 3.1 blockade strongly reduced the growth of xenografted NSCLC cells in mice as measured by positron emission tomography-computed tomography. Thus, loss of DNA methylation of the KCNN4 promoter and increased KCa 3.1 channel expression and function are mechanistically linked to poor survival of NSCLC patients.
© 2015 UICC.

Entities:  

Keywords:  KCa3.1; aggressiveness; lung cancer

Mesh:

Substances:

Year:  2015        PMID: 25704182     DOI: 10.1002/ijc.29490

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  KCNN4 induces multiple chemoresistance in breast cancer by regulating BCL2A1.

Authors:  Peiyang Lin; Junjing Li; Fugui Ye; Wenfen Fu; Xin Hu; Zhiming Shao; Chuangui Song
Journal:  Am J Cancer Res       Date:  2020-10-01       Impact factor: 6.166

Review 2.  Ion Channels in Cancer: Orchestrators of Electrical Signaling and Cellular Crosstalk.

Authors:  Jerry J Fan; Xi Huang
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 3.  Ion Channels in Lung Cancer.

Authors:  Etmar Bulk; Luca Matteo Todesca; Albrecht Schwab
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

4.  KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34.

Authors:  B Bonito; D R P Sauter; A Schwab; M B A Djamgoz; I Novak
Journal:  Pflugers Arch       Date:  2016-10-17       Impact factor: 3.657

5.  In silico analysis of the transportome in human pancreatic ductal adenocarcinoma.

Authors:  A Zaccagnino; C Pilarsky; D Tawfik; S Sebens; A Trauzold; I Novak; A Schwab; H Kalthoff
Journal:  Eur Biophys J       Date:  2016-09-21       Impact factor: 1.733

Review 6.  Zinc transporters and dysregulated channels in cancers.

Authors:  Zui Pan; Sangyong Choi; Halima Ouadid-Ahidouch; Jin-Ming Yang; John H Beattie; Irina Korichneva
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

7.  Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.

Authors:  Bo Chen; Donghong Sun; Xiuni Qin; Xing-Hua Gao
Journal:  Invest New Drugs       Date:  2021-01-26       Impact factor: 3.850

8.  Midazolam's Effects on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-lymphocytes.

Authors:  Ning-Ping Foo; Yu-Fan Liu; Ping-Ching Wu; Chung-Hsi Hsing; Bu-Miin Huang; Edmund-Cheung So
Journal:  Int J Mol Sci       Date:  2021-07-04       Impact factor: 5.923

9.  KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma.

Authors:  Xiao Mo; Cheng-Fei Zhang; Ping Xu; Min Ding; Zhi-Jie Ma; Qi Sun; Yu Liu; Hong-Kai Bi; Xin Guo; Alaa Abdelatty; Chao Hu; Hao-Jun Xu; Guo-Ren Zhou; Yu-Liang Jia; Hong-Ping Xia
Journal:  Acta Pharmacol Sin       Date:  2021-06-28       Impact factor: 6.150

Review 10.  Potassium and Chloride Ion Channels in Cancer: A Novel Paradigm for Cancer Therapeutics.

Authors:  Umberto Banderali; Luigi Leanza; Najmeh Eskandari; Saverio Gentile
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.